Start the conversation
Great news for the CBD industry this week is even better news for penny stock investors. The FDA is making progress on CBD research.
And we know one of the best CBD penny stocks to buy as it happens.
Because they trade for under $5, penny stocks can make huge leaps on small changes. It could be a new drug getting approved by the FDA. Or it could simply be a broader market bounce.
Today, it's both. Our top CBD penny stock is going to thrive on FDA approval. But it's also going to profit from a spike in the CBD industry over the next few years.
The CBD market is still projected to hit $2 billion by the end of 2020… and $20 billion by 2024. And the U.S. Food and Drug Administration is going to help that.
Meanwhile, we'll show you the best CBD stock to watch today. But first, here's how the FDA will eventually drive CBD penny stocks through the roof.
About the Author
Mike Stenger, Associate Editor for Money Morning at Money Map Press, graduated from the Perdue School of Business at Salisbury University. He has combined his degree in Economics with an interest in emerging technologies by finding where tech and finance overlap. Today, he studies the cybersecurity sector, AI, streaming, and the Cloud.